Skip to content

Analysing the Evolution of LDL-C Management: A Review of Emerging Data at the ACC - Post Assessment Survey

Thank you for watching the recent activity 'Analysing the Evolution of LDL-C Management: A Review of Emerging Data at the ACC'. To assess the success of this activity, we would be grateful if you could answer the following short survey.

If you wish to watch again or share with colleagues, you can watch, here.

This Independent Medical Education programme is supported by an unrestricted educational grant from AstraZeneca.
1.Having taken part in this activity, how familiar are you now with the current landscape of hypercholesterolaemia treatments and the barriers to their use?
2.Having taken part in this activity, how familiar are you now with the recent clinical trial data on oral PCSK9 inhibitors and ongoing or upcoming studies?
3.Having taken part in this activity, are you more confident in your ability to discuss the positioning of PCSK9 inhibitors in treatment guidelines and real-world practice?
4.Having taken part in this activity, are you more confident in your ability to evaluate the potential impact of oral PCSK9 inhibitors on clinical decision-making and lipid management strategies?